A technical innovation with great potential, a short time frame and a small budget in the first step while searching further funding was the starting point for the development of the first iteration of the OnDosis brand.
Positioning Narrowing the field from therapeutics to dosage enables building a stronger brand with a more targeted messaging.
Personalized – individualized dosing at the right time enables titration and disease management. Simple – solving the problem of pills that are hard to administer and swallow with an easy-to-use device, and increasing adherence. Revolutionary – leveraging scientific advances in drug development and health technology to improve patient outcomes.
OnDosis is developing a smart drug delivery platform for personalized and connected dosing of medicines. OnDosis builds on a spin out from AstraZeneca with offices in their BioVentureHub in Gothenburg.